MedTrace Logo

Genetic Identification (ID) of Segmental Dysplastic Nevi

NCT00955578 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-08-21

No results posted yet for this study

Summary

The investigators' goal is to identify the mutation in the gene that is responsible for the development of segmental dysplastic nevi. To identify the gene the investigators may use a candidate gene approach (i.e. sequence specific genes that are thought to be involved: NRAS, BRAF, etc) or a genome-wide approach trying to implicate regions in the genome (Loss-of-heterozygosity or copy number changes on comparative genomic hybridization).

Conditions

  • Segmental Dysplastic Nevi

Interventions

PROCEDURE

Punch Biopsy

5-6 punch biopsies of affected areas

Sponsors & Collaborators

  • Nova Scotia Health Authority

    lead OTHER

Principal Investigators

  • Richard GB Langley, MD, FRCPC · Capital Health/Dalhousie University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-12-31
Completion
2010-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00955578 on ClinicalTrials.gov